Tumor suppressor genes (TSGs) and oncogenes (OG) are involved in carcinogenesis. MiRNAs also contribute to cellular pathways leading to cancer. We use data from 217 colorectal cancer (CRC) cases to evaluate differences in TSGs and OGs expression between paired CRC and normal mucosa and evaluate how TSGs and OGs are associated with miRNAs. Gene expression data from RNA-Seq and miRNA expression data from Agilent Human miRNA Microarray V19.0 were used.
| I N TR ODU C TI ON
Tumor suppressor genes (TSGs) play a major role in the carcinogenic process by controlling cell growth and apoptosis, inhibiting the formation of tumors. Mutations in TSGs inactivate their inhibitory function, thereby contributing to the carcinogenic process. Proto-oncogenes likewise are involved in cell growth; when mutated, these oncogenes (OGs) promote cancer through proliferation of cells. Unlike TSGs which require a double hit to inactivate the gene, mutations to OGs are dominant with one copy of the gene needing to be mutated to promote cancer. Several TSGs have been linked to the colorectal cancer (CRC) carcinogenic process, with the adenomatous polyposis coli gene (APC) and TP53 being two of the most commonly mutated TSGs in CRC. 1 Important OGs in CRC include the RAS genes (ie, KRAS, HRAS, and NRAS), BRAF, AKT1, EGFR, PIK3CA, MYC, and JAK. Several of these oncogenes, including KRAS, BRAF, MYC, and PIK3CA have been shown to be mutated and/or have altered expression in colorectal cancer (CRC). [2] [3] [4] Genetic variation in the JAK genes also has been reported as increasing risk of developing CRC. 5 A balance of TSG function and regulation of OGs is needed to control cell growth.
MiRNAs are small, nonprotein-coding RNA molecules involved in the regulation of gene expression either by post-transcriptionally suppressing mRNA translation or by causing mRNA degradation. [6] [7] [8] [9] [10] [11] While the function and importance of miRNAs in the carcinogenic process is not completely understood, it is thought that they help regulate cell attributed to them, are likely part of the elaborate cellular pathways regulated by TSG and OGs. 12, 13 MiRNA expression is frequently either downregulated or up-regulated in CRC tissue when compared to normal mucosa, 14, 15 supporting their relevance to neoplasia. Several miRNAs, including miR-21, miR-203, miR-155, miR-455-3p, and the miR-17-92
cluster interact with TSGs and OGs to influence cancer processes. 13, [16] [17] [18] [19] [20] Groups of miRNAs, such as oncomiR1, are commonly up-regulated in tumor tissue; in turn these miRNAs along with MYC regulate expression of cell cycle transcription factor gene ESF1. 12, 21 MiRNAs have been cited as being "critical effectors of several canonical oncogenic and tumor suppressor pathways". 22 In this study we examine associations between gene expression of 74 TSGs and 59 OGs that have been previously identified as being associated with cancer 23 with miRNA expression levels. It is possible that, in addition to mutation, TSG and OG expression is indicative of dysregulated pathways involved in carcinogenesis and not mutated TSGs or OGs. We evaluate TSGs and OGs with a fold change (FC) between paired tumor and normal tissue 1.5 or 0.67 with miRNAs to have more meaningful levels of expression differences. We believe that insight into the co-regulator roles of TSG, OG, and miRNAs can further our understanding of the carcinogenic process.
| P A TI E NT S A ND M E TH ODS

| Study participants
Study participants come from two population-based case-control studies that included all incident colon and rectal cancer between 30 and 79 years of age in Utah or were members of Kaiser Permanente Medical Care Program (KPMCP) in Northern California. Participants were non-Hispanic white, Hispanic, or black for the colon cancer study;
Asian race was included in the rectal cancer study. 24, 25 Case diagnosis was verified by tumor registry data as a first primary adenocarcinoma of the colon and were diagnosed between October 1991 and September 1994 and for the rectal study were diagnosed between May 1997
and May 2001. Detailed study methods have been described. 15 The
Institutional Review Boards at the University of Utah and at KPMCP approved the study.
| RNA processing
Formalin-fixed paraffin embedded tissue from the initial biopsy or surgery was used to extract RNA. RNA was extracted, isolated and purified as previously described 26 
| miRNA
The Agilent Human miRNA Microarray V19.0 was used (Agilent, St Clara, California). Data were required to pass stringent QC parameters established by Agilent that included tests for excessive background fluorescence, excessive variation among probe sequence replicates on the array, and measures of the total gene signal on the array to assess low signal. Samples failing to meet quality standards were re-labeled, hybridized to arrays, and re-scanned. If a sample failed QC assessment a second time, the sample was excluded from analysis. The repeatability associated with this microarray was extremely high (r 5 0.98), 15 comparison of miRNA expression levels obtained from the Agilent microarray to those obtained from qPCR had an agreement of 100% in terms of directionality of findings and the FCs were almost identical. 14 To normalize differences in miRNA expression that could be attributed to the array, amount of RNA, location on array, or factors that could erroneously influence miRNA expression levels, total gene signal was normalized by multiplying each sample by a scaling factor which was the median of the 75th percentiles of all the samples divided by the individual 75th percentile of each sample. 28 
| Statistical methods
DESeq2 was used to identify TSGs and OGs that had a significant difference in expression between individual paired colorectal carcinoma and normal mucosa adjusting for age and sex. The Bioconductor pack- information Table 4 ). All other up-and down-regulated genes were similar except for AR which had a FC of 0.80 (adjusted P 5 0.04) compared to CRC overall where AR had a FC of 0.6 (adjusted P 5 2.03E-13). For MSS tumors, CTNNB1, which encodes b-catenin, was significantly up-regulated (Supporting information Table 5 ). BRAF and KRAS were not significantly differentially expressed in our data.
Of the 27 OGs that showed statistically significant FCs of 1.5 or 0.67, 12 were associated with miRNA differential expression (Table 5p, miR-375, miR-663a, and miR-93-5p were associated with four
OGs. All but two OGs that were differentially expressed in CRC had a mixture of up-and down-regulated miRNAs associated with them.
CTNNB1, which was up-regulated, was associated with one miRNA (miR-1915-5p) that was also up-regulated; PDGFRA which was downregulated was associated with two miRNAs (miR-145-3p and miR-497-5p) which were also down-regulated.
| D I SCUSSION
Of the 74 TSGs evaluated, 59 were significantly differentially expressed; 22 of these differentially expressed TSGs were more strongly associated with CRC either overall or for MSI and MSS tumors specifically as indicated by a FC 1.5 or 0.67. Of these 22 TSGs, 13
were up-regulated in carcinoma tissue compared to paired normal tis- (Table 6 ). For instance, CYLD negatively regulates NFjB activation and is involved in other immune response mechanisms. 39 When
TSGs such as CYLD are down-regulated, excessive inflammation occurs and tumorigenic factors can be promoted. 40 Conversely, TSGs that were up-regulated were more likely to be involved in cell cycle regulation, apo- TSG that was down-regulated in our data and is associated with NFjBsignaling. 43 Expression of BCL2, which is involved in apoptosis, has also been shown to be regulated by the JAK/STAT-signaling pathway and TGFb-signaling; 44, 45 BCL2 was down-regulated in our data. Other protein tyrosine kinases, such as FLT3, KIT, and EGFR, are classified as receptor protein kinases. All of these OGs were down-regulated in our data and are involved in activation of multiple signaling pathways including cell proliferation, immune response, and angiogenesis. [46] [47] [48] FLT3, part of the VEGF-signaling pathway, is a key element in angiogenesis and ties into P13K/AKT signaling and requires STAT3 for effective cell proliferation. The exact function of miRNAs is not clearly understood; however, our results indicate that they are part of regulatory networks through both direct and indirect effects on OGs and TSGs. It has been suggested that miRNAs work with OGs and TSGs. 13 A study in brain cancer has shown that miR-128 can activate gene expression by repressing nonsense-mediated RNA decay. 50 An example of the complexity of signaling and regulation networks is MYC, a frequently studied OG in cancer. In our data, MYC had a FC of 3.42. MYC has been shown to up-regulate oncomR1, which includes a cluster of six miRNAs, miR-17-5p, miR-18a, miR-19a, miR-20a, miR19b-1, and miR-92. 51 In our data, these miRNAs, except for miR-18a and miR19a, were up-regulated and associated with MYC up-regulation.
Three of the six miRNAs in miR-17-92 cluster also have been regulated in conjunction with the TSGs RBL1, CDKN1A (p21), PTEN, and APC. TSGs that were down-regulated and had immune and inflammationrelated functions. Of these, PRDM1 was previously cited as being down-regulated by several miRNAs including miR-30, miR-9 and miR125b. 53 Five of the six TSGs that were down-regulated, were associated with miR-150-5p which is also down-regulated. All of these TSGs, including GATA3, were associated with inflammation-related pathways such as the NFjB-signaling pathway, suggesting a role in inflammation regulation. However, all of the OGs associated with miR-150-5p, namely SETBP1, JAK3, BCL2, and CSF1R, were also downregulated. These OGs also are involved in inflammation-related pathways. MiR-150-5p expression may be reduced in response to less TSG protein production, as a reduction in target availability is related to miRNA down-regulation, resulting from dissociation of the miRNAinducing silencing complex, which leaves miRNAs vulnerable to degradation. 56 Some of the miRNAs and TSGs were inversely associated.
Examples of these associations were miR-3191-3p (down-regulated) and RNF43 (up-regulated); miR-378d (down) and RNF43 and The study is uniquely suited to examine associations between differential TSG/OG expressions in CRC. Our large sample size offers power to determine significant associations; our use of RNA-Seq data as well as the Agilent miRNA platform allows us to take a discovery approach which enables us to better illuminate pathways of interest.
We looked at TSG/OGs that had higher levels of differential expression, although the cut-points of 1.5 or 0.67 FC was arbitrary. Additionally, we were able to evaluate TSGs/OGs expression with miRNA expression. While we are able to identify numerous associations it is often difficult to determine if associations are direct or indirect in complex biological pathways. Other study strengths include our paired carcinoma and normal mucosa expression data. Having individuals paired data allows us to control for potential confounding effects of genetic and lifestyle factors that could influence both gene and miRNA expression. [57] [58] [59] 62 Similarly, our tumor phenotype data allowed us to investigate differences in gene expression associated with MSS and MSI tumors, as well as TP53-mutated, KRAS-mutated, and BRAFmutated tumors. Our expression data have been shown to have both high repeatability as well as reliability when compared to other ascertainment methods. 14, 15 We encourage others with similar data to undertake replication of our findings in population-based studies as well as laboratory-based studies to better test the proposed functionality.
In summary, our data suggest that several TSG and OGs expression is dysregulated in CRC, suggesting a cellular response to stress.
Our data suggest that miRNAs most likely have both direct and indirect effects on TSG and OGs. It is possible that they work as intermediary regulators between OGs and TSGs, and help to balance upand down-regulation of these genes that can lead to, as well as counter, cell proliferation and apoptosis, which is the hallmark of carcinogenic processes.
